Lantheus Holdings (LNTH) Depreciation & Amortization (CF) (2014 - 2026)
Lantheus Holdings (LNTH) reported Depreciation & Amortization (CF) of $22.7 million for Q1 2026, up 66.47% year-over-year from $13.6 million in Q1 2025, and down 0.66% quarter-over-quarter from $22.8 million in Q4 2025.
Lantheus Holdings (LNTH) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Depreciation & Amortization (CF) data on file, last reported at $22.7 million in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $22.7 million, up 66.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $79.2 million (up 26.03% YoY), and the FY2025 annual result was $70.1 million, up 8.47% from the prior year.
- Depreciation & Amortization (CF) retreated to $22.7 million in Q1 2026 per LNTH's latest filing, from $22.8 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $22.8 million in Q4 2025 and troughed at $11.8 million in Q1 2022.
- A 5-year average of $15.6 million and a median of $14.8 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) retreated 11.78% in 2025, then soared 66.47% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $11.9 million in 2022, then climbed by 26.38% to $15.0 million in 2023, then rose by 15.12% to $17.3 million in 2024, then jumped by 32.1% to $22.8 million in 2025, then fell by 0.66% to $22.7 million in 2026.
- Business Quant data shows LNTH's Depreciation & Amortization (CF) at $22.7 million in Q1 2026, $22.8 million in Q4 2025, and $20.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 22.68 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 21.95 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 497,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.68 Mn |
| Mar 31, 2026 | 22.68 Mn |
| Dec 31, 2025 | 22.83 Mn |
| Dec 31, 2025 | 22.83 Mn |
| Sep 30, 2025 | 20.41 Mn |
| Sep 30, 2025 | 20.41 Mn |
| Jun 30, 2025 | 13.23 Mn |
| Jun 30, 2025 | 13.23 Mn |
| Mar 31, 2025 | 13.63 Mn |
| Mar 31, 2025 | 13.63 Mn |
| Dec 31, 2024 | 17.29 Mn |
| Dec 31, 2024 | 17.29 Mn |
| Sep 30, 2024 | 17.08 Mn |
| Sep 30, 2024 | 17.08 Mn |
| Jun 30, 2024 | 14.82 Mn |
| Jun 30, 2024 | 14.82 Mn |
| Mar 31, 2024 | 15.45 Mn |
| Mar 31, 2024 | 15.45 Mn |
| Dec 31, 2023 | 15.02 Mn |
| Dec 31, 2023 | 15.02 Mn |